Please assess the completion status of the following clinical trial:

Trial Title: Safety, Acceptability, and Feasibility of Enterade®

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Pediatric and caregiver pairs (must meet inclusion criteria for both categories):~Child:~1. Is between 12 and 24 months of age.~2. LAZ between -3 and -1 standard deviations (SD).~3. At least one week post routine immunization, healthy child visit, or vitamin A supplementation visit at the study site.~4. Has a parent or legally acceptable representative willing and able to provide informed consent.~5. No plans for travel outside of the community for the duration of the study.~Caregiver of child:~1. Is a parent or legally accepted representative of a child eligible for this study.~2. Is 18 years of age or older.~3. Has a working mobile phone.~4. Is willing and able to provide informed consent.~5. If illiterate-there is at least one literate adult living in the child's household.~Exclusion Criteria:~Pediatric and caregiver pairs (must meet none of the exclusion criteria for either category):~Child:~1. Has any sign of acute illness, including but not limited to fever, cough, and diarrhea.~2. Is wasted (weight for length z-score \< -2 or mid-upper arm circumference \[MUAC\] \< 12.4 cm) or has pitting edema.~3. Is exclusively breastfed.~4. Is seeking medical attention at the health facility other than for routine, preventative care (e.g., immunization visit, vitamin supplementation).~5. Has suffered within the prior week from illnesses that might impact nutritional status (e.g., severe diarrhea or pneumonia; vomiting; persistent diarrhea; cleft lip or palate; blindness; tuberculosis; jaundice; renal or cardiac disease; cerebral palsy; known metabolic disorders; and chromosomal disorders, including trisomy 21).~6. Medical history of chronic health condition (i.e., HIV, hepatitis B or C, end stage renal disease, severe liver disease-absence of a diagnosis is sufficient).~7. Participating in any other clinical trials.~8. Recent (prior 2 weeks) use of antibiotics or any other medical treatments (including oral re-hydration solution), but not including vaccines or vitamin/mineral supplementation).~9. Cannot give the necessary biological (blood) sample.~Caregiver:~Reports diarrhea in the household in the prior 7 days.

- Gender: ALL
- Minimum Age: 12 Months
- Maximum Age: 24 Months
- Healthy Volunteers: t

Study Arms:
- AA-ORS (Type: EXPERIMENTAL): Those receiving enterade oral re-hydration solution with amino acids
- Placebo (Type: PLACEBO_COMPARATOR): Those receiving placebo solution without amino acids or rehydration salts

Based on this trial design, predict the completion outcome and termination type (if applicable).